Expressmedsp. z o.o. + limited partnership

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-03-02
Registered address
ul. Juliusza Słowackiego 1, 59-400 Jawor, Poland

Financials

Revenue history (in k)

Filing timeliness

1 of 6 financial statements was filed late (for 2021, 94 days late).

  • 202502/06/2026
  • 202414/07/2025
  • 202312/07/2024
  • 202210/07/2023
  • 202117/10/2022
  • 202001/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 3.06mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD 2.66kMedianUSD 20.66kAverageUSD 86.55k
Operating costs
This companyUSD 3.05mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 532.17kMedianUSD 544.32kAverageUSD 1.76m

National Health Fund (NFZ) contracts

Expressmed has been an NFZ healthcare provider since 2025. In 2026 it is performing 1 contract worth USD 363.50. All its contracts were worth USD 937.67 in total.

NFZ contract value by year (USD)

Type of careNFZ branchContractsValue in 2026
Other services provided in pharmaciesdolnośląskie1USD 363.50

Partners

PartnersPartner roleLimited partner contribution
General partner–
Patryk Dorobekage 42
Limited partner5000 PLN
Kamil Abramekage 42
Limited partner5000 PLN
Piotr Jerzy Strzeleckiage 51
Limited partner5000 PLN

Manner of representation

General partner independently

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2016-10-03.

Debt

No entries in the National Debtors Register (KRZ).

Public aid

4 public aid cases recorded, with a total value of $35,659.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,497
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$3,520
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$25,232

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Cefarm RzeszówS.A.
Ms-Pharmsp. z o.o. + limited partnership
Farmjug Agsp. z o.o.
MagmaxS.A.
Adpharmasp. z o.o.
Alfa Pharm - Małgorzata Janusik, Jarosław Janusiksp. j.
Novopharm - Millersp. j.
Pikadasp. z o.o.
Vitasp. z o.o.
Gold Lionsp. z o.o.

FAQ

Last updated: 2026-06-03